Frontlight ResearchEarly access
Trial site
Texas Oncology- Gulf Coast
- 14running trials
- 1closed trial
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Colorectal cancer2 trials
- Bladder cancer1 trial
- Chronic lymphocytic leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Follicular lymphoma1 trial
- Hodgkin lymphoma1 trial
- Immune thrombocytopenia (ITP)1 trial
- Kidney cancer1 trial
- Melanoma1 trial
- Myelodysplastic syndromes1 trial
- and 3 more
- Phase
- Phase 36 trials
- Phase 24 trials
- Phase 1/23 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Recruiting10 trials
- Active, not recruiting4 trials
- Completed1 trial
- Lead sponsor
- Pfizer6 trials
- Hoffmann-La Roche3 trials
- Eli Lilly and Company1 trial
- Faeth Therapeutics1 trial
- Janssen Research & Development, LLC1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Recruiting
Recruiting
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Follicular lymphoma1 recruiting
- Hodgkin lymphoma1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Kidney cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026